#PCSK9 Safety data...long term studies still needed. http://t.co/sO4yngMfjR
Safety and efficacy of iPCSK9: a meta-analysis of 25 RCT. Open access. @PCSK9Forum @fhscglobal http://t.co/DzLgN8oMw2
Safety and efficacy of iPCSK9: a meta-analysis of 25 RCT. Open access. @PCSK9Forum @fhscglobal http://t.co/DzLgN8oMw2
Anti-PCSK9 antibodies could have a beneficial effect on lipid profiles and reduce cardiovascular risk: http://t.co/8mswGDuHcb
Anti-PCSK9 antibodies could have a beneficial effect on lipid profiles and reduce cardiovascular risk: http://t.co/8mswGDuHcb
Anti-PCSK9 antibodies could have a beneficial effect on lipid profiles and reduce cardiovascular risk: http://t.co/8mswGDuHcb
Anti-PCSK9 antibodies could have a beneficial effect on lipid profiles and reduce cardiovascular risk: http://t.co/8mswGDuHcb
New #metaanalysis: anti-PCSK9 antibodies improve lipid profiles and could reduce #cardiovascular risk http://t.co/h6EX5ULcEx
“@FarmaciaOesteAP: (BMC Medicine) Seguridad y eficacia de los anticuerpos anti-PCSK9; metaanálisis http://t.co/5mNNyMlNdp”
(BMC Medicine) Seguridad y eficacia de los anticuerpos anti-PCSK9; metaanálisis http://t.co/jKlPGx7D8G
Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials http://t.co/bOmiKHne3A